The incubation centre at the Government Institute of Medical Sciences (GIMS) has secured Rs 16.6 crore in seed funding through one of its incubated startups, Sophrosyne Technologies. The funding round was led by technology-focused investment firm Bluehill VC.

GIMS hosts the state’s first government-run incubation centre, established to drive innovation in medtech, digital health, and deep-tech. Sophrosyne Technologies, one of its key startups, is developing an ultra-low-power, unified biosensing System-on-Chip (SoC) capable of measuring ECG, PPG, respiration, and temperature. Designed as a compact semiconductor solution, the SoC aims to power the next generation of wearable devices for continuous health monitoring.

ALSO READ: Bihar Sets Monthly Deadline To Ensure Timely Old-Age Pension Transfers, Orders Accountability For Delays

The startup has previously received support under the Government of India’s Design Linked Incentive (DLI) scheme of the Ministry of Electronics and Information Technology. The newly raised capital will be used to transition from prototype silicon to production-grade development, strengthen the silicon design and firmware teams, and begin OEM engagement in both Indian and global markets.

Dr Rahul Singh, CEO of the GIMS incubation centre, said Sophrosyne Technologies is developing India’s own medical-grade chipsets for advanced wearables and clinical devices. The startup was founded by Dr Manish Shrivastava, a PhD from University College Cork, Ireland, and Jatin Gupta, who has global experience in strategy and operations.

ALSO READ: Delhi Air Pollution Protest: 'Madvi Hidma Amar Rahe' Slogan Raised At India Gate; Police Assure Action 

With India still dependent on imported chipsets for health and medical devices, Sophrosyne Technologies aims to change this by creating indigenous, ultra-low-power, clinically accurate health chipsets featuring multi-vital biosensing, smart power management, and AI-based real-time risk detection. The company is also working on energy-harvesting technology to support future invasive and non-invasive medical devices.

GIMS Director Brigadier Dr Rakesh Gupta said the success of the startup demonstrates that world-class medical and semiconductor innovation can emerge from a public hospital ecosystem when backed by the right structure, vision, and clinical integration.